Cohance Lifesciences Limited — Updates, 02-12-2025: General Updates
02-12-2025 | 09:57 pm
02-12-2025 | 09:57 pm
Cohance Lifesciences approved investing up to USD 10 million in its US subsidiary, NJ Bio Inc. This fund infusion will support NJ Bio's growth initiatives and capex.
No comments yet. Be the first to comment!
